Form 4 for DMAA Drugs Made In America Acquisition Corp.
Accepted 2025-02-03 00:00:00 ET · period of report 2025-01-29 · accession 0001213900-25-009600 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-03 | 2025-01-29 | DMAA | Prasad Sridhar G. | Dir | J - Other | — | +100.0K | 100.0K | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary shares | 2025-01-29 | J | A | 100,000 | — | 100,000 | D | — | — | (F1) As of the Transaction Date, the reporting person acquired 100,000 ordinary shares from Drugs Made In America Acquisition LLC, the Issuer's sponsor, for no consideration. |